ANGPT2 and neoplasm: Additionally, IFN-γ can activate the AKT-FOXO1 signaling pathway in ECs, thereby indirectly suppressing the mRNA expression of ANGPT2. Finally, PD-L1 blockade therapy effectively restrains tumor angiogenesis and vascular destabilization in LUAD (Figure 6).